Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Mark Rubin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Physiology

Procedures

Concepts & Ideas

Devices

Oligonucleotide Array Sequence Analysis

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Touma Sue Ellen; Perner Sven; Rubin Mark A; Nanus David M; Gudas Lorraine J
Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model.
Wagner Patrick L; Perner Sven; Rickman David S; LaFargue Christopher J; Kitabayashi Naoki; Johnstone Stephen F; Weir Barbara A; Meyerson Matthew; Altorki Nasser K; Rubin Mark A
In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma.
Pflueger Dorothee; Rickman David S; Sboner Andrea; Perner Sven; LaFargue Christopher J; Svensson Maria A; Moss Benjamin J; Kitabayashi Naoki; Pan Yihang; de la Taille Alexandre; Kuefer Rainer; Tewari Ashutosh K; Demichelis Francesca; Chee Mark S; Gerstein Mark B; Rubin Mark A
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mark Rubin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Touma Sue Ellen; Perner Sven; Rubin Mark A; Nanus David M; Gudas Lorraine J
Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model.
Biochemical pharmacology 2009;78(9):1127-38.
2009: Wagner Patrick L; Perner Sven; Rickman David S; LaFargue Christopher J; Kitabayashi Naoki; Johnstone Stephen F; Weir Barbara A; Meyerson Matthew; Altorki Nasser K; Rubin Mark A
In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma.
American journal of clinical pathology 2009;132(4):500-5.
2009: Pflueger Dorothee; Rickman David S; Sboner Andrea; Perner Sven; LaFargue Christopher J; Svensson Maria A; Moss Benjamin J; Kitabayashi Naoki; Pan Yihang; de la Taille Alexandre; Kuefer Rainer; Tewari Ashutosh K; Demichelis Francesca; Chee Mark S; Gerstein Mark B; Rubin Mark A
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.
Neoplasia (New York, N.Y.) 2009;11(8):804-11.
2009: Tomlins Scott A; Bjartell Anders; Chinnaiyan Arul M; Jenster Guido; Nam Robert K; Rubin Mark A; Schalken Jack A
ETS gene fusions in prostate cancer: from discovery to daily clinical practice.
European urology 2009;56(2):275-86.
2009: Wang Qianben; Li Wei; Zhang Yong; Yuan Xin; Xu Kexin; Yu Jindan; Chen Zhong; Beroukhim Rameen; Wang Hongyun; Lupien Mathieu; Wu Tao; Regan Meredith M; Meyer Clifford A; Carroll Jason S; Manrai Arjun Kumar; Jänne Olli A; Balk Steven P; Mehra Rohit; Han Bo; Chinnaiyan Arul M; Rubin Mark A; True Lawrence; Fiorentino Michelangelo; Fiore Christopher; Loda Massimo; Kantoff Philip W; Liu X Shirley; Brown Myles
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.
Cell 2009;138(2):245-56.
2009: Mosquera Juan-Miguel; Mehra Rohit; Regan Meredith M; Perner Sven; Genega Elizabeth M; Bueti Gerri; Shah Rajal B; Gaston Sandra; Tomlins Scott A; Wei John T; Kearney Michael C; Johnson Laura A; Tang Jeffrey M; Chinnaiyan Arul M; Rubin Mark A; Sanda Martin G
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(14):4706-11.
2009: Haack Herbert; Johnson Laura A; Fry Christopher J; Crosby Katherine; Polakiewicz Roberto D; Stelow Edward B; Hong Seung-Mo; Schwartz Brian E; Cameron Michael J; Rubin Mark A; Chang Martin C; Aster Jon C; French Christopher A
Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody.
The American journal of surgical pathology 2009;33(7):984-91.
2009: Setlur Sunita R; Mertz Kirsten D; Rubin Mark A
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.
BJU international 2009;103(9):1293; author reply 1293.
2009: Steinkamp Mara P; O'Mahony Orla A; Brogley Michele; Rehman Haniya; Lapensee Elizabeth W; Dhanasekaran Saravana; Hofer Matthias D; Kuefer Rainer; Chinnaiyan Arul; Rubin Mark A; Pienta Kenneth J; Robins Diane M
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy.
Cancer research 2009;69(10):4434-42.
2009: Rickman David S; Pflueger Dorothee; Moss Benjamin; VanDoren Vanessa E; Chen Chen X; de la Taille Alexandre; Kuefer Rainer; Tewari Ashutosh K; Setlur Sunita R; Demichelis Francesca; Rubin Mark A
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
Cancer research 2009;69(7):2734-8.
2009: Demichelis Francesca; Setlur Sunita R; Beroukhim Rameen; Perner Sven; Korbel Jan O; Lafargue Christopher J; Pflueger Dorothee; Pina Cara; Hofer Matthias D; Sboner Andrea; Svensson Maria A; Rickman David S; Urban Alex; Snyder Michael; Meyerson Matthew; Lee Charles; Gerstein Mark B; Kuefer Rainer; Rubin Mark A
Distinct genomic aberrations associated with ERG rearranged prostate cancer.
Genes, chromosomes & cancer 2009;48(4):366-80.
2009: Dhillon Preet K; Barry Marc; Stampfer Meir J; Perner Sven; Fiorentino Michelangelo; Fornari Alessandro; Ma Jing; Fleet Julia; Kurth Tobias; Rubin Mark A; Mucci Lorelei A
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(2):595-600.
2009: Hofer Matthias D; Kuefer Rainer; Maier Christiane; Herkommer Kathleen; Perner Sven; Demichelis Francesca; Paiss Thomas; Vogel Walter; Rubin Mark A; Hoegel Josef
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
Cancer research 2009;69(2):640-6.
2009: Paris P L; Sridharan S; Hittelman A B; Kobayashi Y; Perner S; Huang G; Simko J; Carroll P; Rubin M A; Collins C
An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer.
Prostate cancer and prostatic diseases 2009;12(2):184-91.
2008: Varambally Sooryanarayana; Laxman Bharathi; Mehra Rohit; Cao Qi; Dhanasekaran Saravana M; Tomlins Scott A; Granger Jill; Vellaichamy Adaikkalam; Sreekumar Arun; Yu Jianjun; Gu Wenjuan; Shen Ronglai; Ghosh Debashis; Wright Lorinda M; Kladney Raleigh D; Kuefer Rainer; Rubin Mark A; Fimmel Claus J; Chinnaiyan Arul M
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.
Neoplasia (New York, N.Y.) 2008;10(11):1285-94.
2008: Mertz Kirsten D; Demichelis Francesca; Sboner Andrea; Hirsch Michelle S; Dal Cin Paola; Struckmann Kirsten; Storz Martina; Scherrer Simone; Schmid Daniel M; Strebel Räto T; Probst-Hensch Nicole M; Gerstein Mark; Moch Holger; Rubin Mark A
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer.
International journal of cancer. Journal international du cancer 2008;123(3):569-76.
2008: Mucci Lorelei A; Pawitan Yudi; Demichelis Francesca; Fall Katja; Stark Jennifer R; Adami Hans-Olov; Andersson Swen-Olof; Andrén Ove; Eisenstein Anna; Holmberg Lars; Huang Wei; Kantoff Philip W; Kim Robert; Perner Sven; Stampfer Meir J; Johansson Jan-Erik; Rubin Mark A
Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(7):1682-8.
2008: Mosquera Juan-Miguel; Perner Sven; Genega Elizabeth M; Sanda Martin; Hofer Matthias D; Mertz Kirsten D; Paris Pamela L; Simko Jeff; Bismar Tarek A; Ayala Gustavo; Shah Rajal B; Loda Massimo; Rubin Mark A
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3380-5.
2008: Setlur Sunita R; Mertz Kirsten D; Hoshida Yujin; Demichelis Francesca; Lupien Mathieu; Perner Sven; Sboner Andrea; Pawitan Yudi; Andrén Ove; Johnson Laura A; Tang Jeff; Adami Hans-Olov; Calza Stefano; Chinnaiyan Arul M; Rhodes Daniel; Tomlins Scott; Fall Katja; Mucci Lorelei A; Kantoff Philip W; Stampfer Meir J; Andersson Swen-Olof; Varenhorst Eberhard; Johansson Jan-Erik; Brown Myles; Golub Todd R; Rubin Mark A
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
Journal of the National Cancer Institute 2008;100(11):815-25.
2008: Mehra Rohit; Tomlins Scott A; Yu Jianjun; Cao Xuhong; Wang Lei; Menon Anjana; Rubin Mark A; Pienta Kenneth J; Shah Rajal B; Chinnaiyan Arul M
Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.
Cancer research 2008;68(10):3584-90.
2008: Hodge Jennelle C; Quade Bradley J; Rubin Mark A; Stewart Elizabeth A; Dal Cin Paola; Morton Cynthia C
Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.
The American journal of pathology 2008;172(5):1403-10.
2008: Neeley Yilin C; Arredouani Mohamed S; Hollenbeck Brent; Eng Marvin H; Rubin Mark A; Sanda Martin G
Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
The Prostate 2008;68(7):715-27.
2008: Kelly Kimberly A; Setlur Sunita R; Ross Robert; Anbazhagan Rajesh; Waterman Peter; Rubin Mark A; Weissleder Ralph
Detection of early prostate cancer using a hepsin-targeted imaging agent.
Cancer research 2008;68(7):2286-91.
2008: Demichelis Francesca; Greulich Heidi; Macoska Jill A; Beroukhim Rameen; Sellers William R; Garraway Levi; Rubin Mark A
SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines.
Nucleic acids research 2008;36(7):2446-56.
2008: Tomlins Scott A; Laxman Bharathi; Varambally Sooryanarayana; Cao Xuhong; Yu Jindan; Helgeson Beth E; Cao Qi; Prensner John R; Rubin Mark A; Shah Rajal B; Mehra Rohit; Chinnaiyan Arul M
Role of the TMPRSS2-ERG gene fusion in prostate cancer.
Neoplasia (New York, N.Y.) 2008;10(2):177-88.
2008: Mucci Lorelei A; Pawitan Yudi; Demichelis Francesca; Fall Katja; Stark Jennifer R; Adami Hans-Olov; Andersson Swen-Olof; Andrén Ove; Eisenstein Anna S; Holmberg Lars; Huang Wei; Kantoff Philip W; Perner Sven; Stampfer Meir J; Johansson Jan-Erik; Rubin Mark A
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(1):249-51.
2007: Setlur Sunita R; Royce Thomas E; Sboner Andrea; Mosquera Juan-Miguel; Demichelis Francesca; Hofer Matthias D; Mertz Kirsten D; Gerstein Mark; Rubin Mark A
Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer.
Cancer research 2007;67(21):10296-303.
2007: Barry Marc; Perner Sven; Demichelis Francesca; Rubin Mark A
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications.
Urology 2007;70(4):630-3.
2007: Mertz Kirsten D; Demichelis Francesca; Kim Robert; Schraml Peter; Storz Martina; Diener Pierre-André; Moch Holger; Rubin Mark A
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer.
Human pathology 2007;38(10):1454-62.
2007: Kim Jung H; Dhanasekaran Saravana M; Mehra Rohit; Tomlins Scott A; Gu Wenjuan; Yu Jianjun; Kumar-Sinha Chandan; Cao Xuhong; Dash Atreya; Wang Lei; Ghosh Debashis; Shedden Kerby; Montie James E; Rubin Mark A; Pienta Kenneth J; Shah Rajal B; Chinnaiyan Arul M
Integrative analysis of genomic aberrations associated with prostate cancer progression.
Cancer research 2007;67(17):8229-39.
2007: Andrén O; Fall K; Andersson S-O; Rubin M A; Bismar T A; Karlsson M; Johansson J-E; Mucci L A
MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden.
British journal of cancer 2007;97(6):730-4.
2007: Tomlins Scott A; Laxman Bharathi; Dhanasekaran Saravana M; Helgeson Beth E; Cao Xuhong; Morris David S; Menon Anjana; Jing Xiaojun; Cao Qi; Han Bo; Yu Jindan; Wang Lei; Montie James E; Rubin Mark A; Pienta Kenneth J; Roulston Diane; Shah Rajal B; Varambally Sooryanarayana; Mehra Rohit; Chinnaiyan Arul M
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Nature 2007;448(7153):595-9.
2007: Demichelis F; Fall K; Perner S; Andrén O; Schmidt F; Setlur S R; Hoshida Y; Mosquera J-M; Pawitan Y; Lee C; Adami H-O; Mucci L A; Kantoff P W; Andersson S-O; Chinnaiyan A M; Johansson J-E; Rubin M A
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
Oncogene 2007;26(31):4596-9.
2007: Perner Sven; Mosquera Juan-Miguel; Demichelis Francesca; Hofer Matthias D; Paris Pamela L; Simko Jeff; Collins Colin; Bismar Tarek A; Chinnaiyan Arul M; De Marzo Angelo M; Rubin Mark A
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.
The American journal of surgical pathology 2007;31(6):882-8.
2007: Mosquera J-M; Perner S; Demichelis F; Kim R; Hofer M D; Mertz K D; Paris P L; Simko J; Collins C; Bismar T A; Chinnaiyan A M; Rubin M A
Morphological features of TMPRSS2-ERG gene fusion prostate cancer.
The Journal of pathology 2007;212(1):91-101.
2007: Mehra Rohit; Tomlins Scott A; Shen Ronglai; Nadeem Owais; Wang Lei; Wei John T; Pienta Kenneth J; Ghosh Debashis; Rubin Mark A; Chinnaiyan Arul M; Shah Rajal B
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(5):538-44.
2007: Perner Sven; Hofer Matthias D; Kim Robert; Shah Rajal B; Li Haojie; Möller Peter; Hautmann Richard E; Gschwend Juergen E; Kuefer Rainer; Rubin Mark A
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
Human pathology 2007;38(5):696-701.
2007: Prince Mark E; Ubell Mathew L; Castro Jason; Ogawa Haruko; Ogawa Tetsuya; Narayan Ajita; Paulino Augusto; Cole Andrew; Wolf Gregory T; Rubin Mark A; Lyons Robert H; Bradford Carol R; Carey Thomas E
Tissue-preserving approach to extracting DNA from paraffin-embedded specimens using tissue microarray technology.
Head & neck 2007;29(5):465-71.
2007: Mertz Kirsten D; Setlur Sunita R; Dhanasekaran Saravana M; Demichelis Francesca; Perner Sven; Tomlins Scott; Tchinda Joëlle; Laxman Bharathi; Vessella Robert L; Beroukhim Rameen; Lee Charles; Chinnaiyan Arul M; Rubin Mark A
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.
Neoplasia (New York, N.Y.) 2007;9(3):200-6.
2007: Tomlins Scott A; Mehra Rohit; Rhodes Daniel R; Cao Xuhong; Wang Lei; Dhanasekaran Saravana M; Kalyana-Sundaram Shanker; Wei John T; Rubin Mark A; Pienta Kenneth J; Shah Rajal B; Chinnaiyan Arul M
Integrative molecular concept modeling of prostate cancer progression.
Nature genetics 2007;39(1):41-51.
2006: Paris Pamela L; Hofer Matthias D; Albo Giancarlo; Kuefer Rainer; Gschwend Juergen E; Hautmann Richard E; Fridyland Jane; Simko Jeffrey; Carroll Peter R; Rubin Mark A; Collins Colin
Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer.
Neoplasia (New York, N.Y.) 2006;8(12):1083-9.
2006: Davis Joanne N; Wojno Kirk J; Daignault Stephanie; Hofer Matthias D; Kuefer Rainer; Rubin Mark A; Day Mark L
Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Cancer research 2006;66(24):11897-906.
2006: Laxman Bharathi; Tomlins Scott A; Mehra Rohit; Morris David S; Wang Lei; Helgeson Beth E; Shah Rajal B; Rubin Mark A; Wei John T; Chinnaiyan Arul M
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.
Neoplasia (New York, N.Y.) 2006;8(10):885-8.
2006: Perner Sven; Demichelis Francesca; Beroukhim Rameen; Schmidt Folke H; Mosquera Juan-Miguel; Setlur Sunita; Tchinda Joelle; Tomlins Scott A; Hofer Matthias D; Pienta Kenneth G; Kuefer Rainer; Vessella Robert; Sun Xiao-Wei; Meyerson Matthew; Lee Charles; Sellers William R; Chinnaiyan Arul M; Rubin Mark A
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
Cancer research 2006;66(17):8337-41.
2006: Hofer Matthias D; Tapia Coya; Browne Tara Jane; Mirlacher Martina; Sauter Guido; Rubin Mark A
Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue.
Archives of pathology & laboratory medicine 2006;130(7):989-96.
2006: Descazeaud Aurelien; de la Taille Alexandre; Allory Yves; Faucon Hugo; Salomon Laurent; Bismar Tarek; Kim Robert; Hofer Matthias D; Chopin Dominique; Abbou Claude C; Rubin Mark A
Characterization of ZAG protein expression in prostate cancer using a semi-automated microscope system.
The Prostate 2006;66(10):1037-43.
2006: Oh William K; Hayes Julia; Evan Carolyn; Manola Judith; George Daniel J; Waldron Helen; Donovan Meaghan; Varner John; Orechia John; Katcher Beth; Lu Diana; Nevins Arthur; Wright Renée L; Tormey Lauren; Talcott James; Rubin Mark A; Loda Massimo; Sellers William R; Richie Jerome P; Kantoff Philip W; Weeks Jane
Development of an integrated prostate cancer research information system.
Clinical genitourinary cancer 2006;5(1):61-6.
2006: Beroukhim Rameen; Lin Ming; Park Yuhyun; Hao Ke; Zhao Xiaojun; Garraway Levi A; Fox Edward A; Hochberg Ephraim P; Mellinghoff Ingo K; Hofer Matthias D; Descazeaud Aurelien; Rubin Mark A; Meyerson Matthew; Wong Wing Hung; Sellers William R; Li Cheng
Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.
PLoS computational biology 2006;2(5):e41.
2006: Hofer Matthias D; Kuefer Rainer; Huang Wei; Li Haojie; Bismar Tarek A; Perner Sven; Hautmann Richard E; Sanda Martin G; Gschwend Juergen E; Rubin Mark A
Prognostic factors in lymph node-positive prostate cancer.
Urology 2006;67(5):1016-21.
2006: Kuefer Rainer; Day Kathleen C; Kleer Celina G; Sabel Michael S; Hofer Matthias D; Varambally Sooryanarayana; Zorn Christoph S; Chinnaiyan Arul M; Rubin Mark A; Day Mark L
ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.
Neoplasia (New York, N.Y.) 2006;8(4):319-29.
2006: Tomlins Scott A; Mehra Rohit; Rhodes Daniel R; Smith Lisa R; Roulston Diane; Helgeson Beth E; Cao Xuhong; Wei John T; Rubin Mark A; Shah Rajal B; Chinnaiyan Arul M
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.
Cancer research 2006;66(7):3396-400.
2006: Andrén Ove; Fall Katja; Franzén Lennart; Andersson Swen-Olof; Johansson Jan-Erik; Rubin Mark A
How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden.
The Journal of urology 2006;175(4):1337-40.
2006: Mertz K D; Tchinda J; Küfer R; Möller P; Rubin M A; Moch H; Perner S
[Cytogenetic alterations in renal tumors. Applications for comparative genomic hybridization and fluorescence in situ hybridization]
Der Urologe. Ausg. A 2006;45(3):316-8, 320-2.
2006: Tomlins Scott A; Mehra Rohit; Rhodes Daniel R; Shah Rajal B; Rubin Mark A; Bruening Eric; Makarov Vladimir; Chinnaiyan Arul M
Whole transcriptome amplification for gene expression profiling and development of molecular archives.
Neoplasia (New York, N.Y.) 2006;8(2):153-62.
2006: Bismar Tarek A; Demichelis Francesca; Riva Alberto; Kim Robert; Varambally Sooryanarayana; He Le; Kutok Jeff; Aster Jonathan C; Tang Jeffery; Kuefer Rainer; Hofer Matthias D; Febbo Phillip G; Chinnaiyan Arul M; Rubin Mark A
Defining aggressive prostate cancer using a 12-gene model.
Neoplasia (New York, N.Y.) 2006;8(1):59-68.
2006: Tomlins Scott A; Rubin Mark A; Chinnaiyan Arul M
Integrative biology of prostate cancer progression.
Annual review of pathology 2006;1():243-71.
2005: Descazeaud Aurélien; Rubin Mark A; Allory Yves; Burchardt Martin; Salomon Laurent; Chopin Dominique; Abbou Claude; de la Taille Alexandre
What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?
European urology 2005;48(6):911-5.
2005: Koochekpour Shahriar; Zhuang Yu-Jun; Beroukhim Rameen; Hsieh Chia-Ling; Hofer Matthias D; Zhau Haiyen E; Hiraiwa Masao; Pattan Daniel Y; Ware Joy L; Luftig Ronald B; Sandhoff Konrad; Sawyers Charles L; Pienta Kenneth J; Rubin Mark A; Vessella Robert L; Sellers William R; Sartor Oliver
Amplification and overexpression of prosaposin in prostate cancer.
Genes, chromosomes & cancer 2005;44(4):351-64.
2005: Varambally Sooryanarayana; Yu Jianjun; Laxman Bharathi; Rhodes Daniel R; Mehra Rohit; Tomlins Scott A; Shah Rajal B; Chandran Uma; Monzon Federico A; Becich Michael J; Wei John T; Pienta Kenneth J; Ghosh Debashis; Rubin Mark A; Chinnaiyan Arul M
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
Cancer cell 2005;8(5):393-406.
2005: Rubin Mark A; Allory Yves; Molinié Vincent; Leroy Xavier; Faucon Hugo; Vacherot Francis; Huang Wei; Kuten Adam; Salomon Laurent; Rebillard Xavier; Cussenot Olivier; Abbou Claude; de la Taille Alexandre
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome.
Urology 2005;66(5):930-4.
2005: Tomlins Scott A; Rhodes Daniel R; Perner Sven; Dhanasekaran Saravana M; Mehra Rohit; Sun Xiao-Wei; Varambally Sooryanarayana; Cao Xuhong; Tchinda Joelle; Kuefer Rainer; Lee Charles; Montie James E; Shah Rajal B; Pienta Kenneth J; Rubin Mark A; Chinnaiyan Arul M
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Science (New York, N.Y.) 2005;310(5748):644-8.
2005: Tantivejkul Kwanchanit; Loberg Robert D; Mawocha Samkeliso C; Day Lashon L; John Lauren St; Pienta Brian A; Rubin Mark A; Pienta Kenneth J
PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism.
Journal of cellular biochemistry 2005;96(3):641-52.
2005: Setlur Sunita R; Rubin Mark A
Current thoughts on the role of the androgen receptor and prostate cancer progression.
Advances in anatomic pathology 2005;12(5):265-70.
2005: Wang Xiaoju; Yu Jianjun; Sreekumar Arun; Varambally Sooryanarayana; Shen Ronglai; Giacherio Donald; Mehra Rohit; Montie James E; Pienta Kenneth J; Sanda Martin G; Kantoff Philip W; Rubin Mark A; Wei John T; Ghosh Debashis; Chinnaiyan Arul M
Autoantibody signatures in prostate cancer.
The New England journal of medicine 2005;353(12):1224-35.
2005: Hofer Matthias D; Browne Tara J; He Le; Skotheim Rolf I; Lothe Ragnhild A; Rubin Mark A
Identification of two molecular groups of seminomas by using expression and tissue microarrays.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5722-9.
2005: Paris P L; Weinberg V; Simko J; Andaya A; Albo G; Rubin M A; Carroll P R; Collins C
Preliminary evaluation of prostate cancer metastatic risk biomarkers.
The International journal of biological markers 2005;20(3):141-5.
2005: Garraway Levi A; Widlund Hans R; Rubin Mark A; Getz Gad; Berger Aaron J; Ramaswamy Sridhar; Beroukhim Rameen; Milner Danny A; Granter Scott R; Du Jinyan; Lee Charles; Wagner Stephan N; Li Cheng; Golub Todd R; Rimm David L; Meyerson Matthew L; Fisher David E; Sellers William R
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
Nature 2005;436(7047):117-22.
2005: Dimitroff Charles J; Descheny Leyla; Trujillo Natalia; Kim Robert; Nguyen Vuong; Huang Wei; Pienta Kenneth J; Kutok Jeffery L; Rubin Mark A
Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells.
Cancer research 2005;65(13):5750-60.
2005: Zhao Xiaojun; Weir Barbara A; LaFramboise Thomas; Lin Ming; Beroukhim Rameen; Garraway Levi; Beheshti Javad; Lee Jeffrey C; Naoki Katsuhiko; Richards William G; Sugarbaker David; Chen Fei; Rubin Mark A; Jänne Pasi A; Girard Luc; Minna John; Christiani David; Li Cheng; Sellers William R; Meyerson Matthew
Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis.
Cancer research 2005;65(13):5561-70.
2005: Browne Tara-Jane; Richie Jerome P; Gilligan Timothy D; Rubin Mark A
Intertubular growth in pure seminomas: associations with poor prognostic parameters.
Human pathology 2005;36(6):640-5.
2005: Rubin Mark A; Bismar Tarek A; Andrén Ove; Mucci Lorelei; Kim Robert; Shen Ronglai; Ghosh Debashis; Wei John T; Chinnaiyan Arul M; Adami Hans-Olov; Kantoff Philip W; Johansson Jan-Erik
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1424-32.
2005: Witkiewicz Agnieszka K; Varambally Sooryanarayana; Shen Ronglai; Mehra Rohit; Sabel Michael S; Ghosh Debashis; Chinnaiyan Arul M; Rubin Mark A; Kleer Celina G
Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1418-23.
2005: Lin Darlene D; Schultz Delray; Renshaw Andrew A; Rubin Mark A; Richie Jerome P; D'Amico Anthony V
Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era.
Urology 2005;65(3):528-32.
2005: Dhanasekaran Saravana Mohan; Dash Atreya; Yu Jianjun; Maine Ira P; Laxman Bharathi; Tomlins Scott A; Creighton Chad J; Menon Anjana; Rubin Mark A; Chinnaiyan Arul M
Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(2):243-5.
2005: Garraway L A; Weir B A; Zhao X; Widlund H; Beroukhim R; Berger A; Rimm D; Rubin M A; Fisher D E; Meyerson M L; Sellers W R
"Lineage addiction" in human cancer: lessons from integrated genomics.
Cold Spring Harbor symposia on quantitative biology 2005;70():25-34.
2005: Kim Robert; Demichelis Francesca; Tang Jeffery; Riva Alberto; Shen Ronglai; Gibbs Doug F; Mahavishno Vasudeva; Chinnaiyan Arul M; Rubin Mark A
Internet-based Profiler system as integrative framework to support translational research.
BMC bioinformatics 2005;6():304.
2004: Browne Tara-Jane; Hirsch Michelle S; Brodsky Gilbert; Welch William R; Loda Massimo F; Rubin Mark A
Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
Human pathology 2004;35(12):1462-8.
2004: Shah Rajal B; Mehra Rohit; Chinnaiyan Arul M; Shen Ronglai; Ghosh Debashis; Zhou Ming; Macvicar Gary R; Varambally Soorynarayana; Harwood Jason; Bismar Tarek A; Kim Robert; Rubin Mark A; Pienta Kenneth J
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.
Cancer research 2004;64(24):9209-16.
2004: Rubin Mark A
Using molecular markers to predict outcome.
The Journal of urology 2004;172(5 Pt 2):S18-21; discussion S21-2.
2004: Carroll Peter R; Chan June M L; D'Amico Anthony V; Gelmann Edward P; Iversen Peter; Klotz Laurence; Nelson Joel B; Nelson Peter S; Nelson William G; Oh William K; Rosen Neal; Rubin Mark A; Sandler Howard; Sellers William R; Smith Matthew R; Xu Jianfeng; McMann Mary C; Kantoff Philip W
Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment.
The Journal of urology 2004;172(5 Pt 2):S3-5.
2004: Shah Rajal B; Kunju Lakshmi P; Shen Ronglai; LeBlanc Michele; Zhou Ming; Rubin Mark A
Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.
American journal of clinical pathology 2004;122(4):517-23.
2004: Santagata Sandro; Demichelis Francesca; Riva Alberto; Varambally Sooryanarayana; Hofer Matthias D; Kutok Jeffery L; Kim Robert; Tang Jeffery; Montie James E; Chinnaiyan Arul M; Rubin Mark A; Aster Jon C
JAGGED1 expression is associated with prostate cancer metastasis and recurrence.
Cancer research 2004;64(19):6854-7.
2004: Hofer Matthias D; Fecko Alice; Shen Ronglai; Setlur Sunita R; Pienta Kenneth G; Tomlins Scott A; Chinnaiyan Arul M; Rubin Mark A
Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
Neoplasia (New York, N.Y.) 2004;6(5):503-12.
2004: Rubin Mark A; Bismar Tarek A; Curtis Sarah; Montie James E
Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?
The American journal of surgical pathology 2004;28(7):946-52.
2004: Paris Pamela L; Andaya Armann; Fridlyand Jane; Jain Ajay N; Weinberg Vivian; Kowbel David; Brebner John H; Simko Jeff; Watson J E Vivienne; Volik Stas; Albertson Donna G; Pinkel Daniel; Alers Janneke C; van der Kwast Theodorus H; Vissers Kees J; Schroder Fritz H; Wildhagen Mark F; Febbo Phillip G; Chinnaiyan Arul M; Pienta Kenneth J; Carroll Peter R; Rubin Mark A; Collins Colin; van Dekken Herman
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors.
Human molecular genetics 2004;13(13):1303-13.
2004: Sreekumar Arun; Laxman Bharathi; Rhodes Daniel R; Bhagavathula Srilakshmi; Harwood Jason; Giacherio Donald; Ghosh Debashis; Sanda Martin G; Rubin Mark A; Chinnaiyan Arul M
Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer.
Journal of the National Cancer Institute 2004;96(11):834-43.
2004: Rubin Mark A; Varambally Sooryanarayana; Beroukhim Rameen; Tomlins Scott A; Rhodes Daniel R; Paris Pamela L; Hofer Matthias D; Storz-Schweizer Martina; Kuefer Rainer; Fletcher Jonathan A; Hsi Bae-Li; Byrne Jennifier A; Pienta Kenneth J; Collins Colin; Sellers William R; Chinnaiyan Arul M
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.
Cancer research 2004;64(11):3814-22.
2004: Schmalbach Cecelia E; Chepeha Douglas B; Giordano Thomas J; Rubin Mark A; Teknos Theodoros N; Bradford Carol R; Wolf Gregory T; Kuick Rork; Misek David E; Trask Douglas K; Hanash Samir
Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma.
Archives of otolaryngology--head & neck surgery 2004;130(3):295-302.
2004: Rubin Mark A; Zerkowski Maciej P; Camp Robert L; Kuefer Rainer; Hofer Matthias D; Chinnaiyan Arul M; Rimm David L
Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
The American journal of pathology 2004;164(3):831-40.
2004: Kumar-Sinha Chandan; Shah Rajal B; Laxman Bharathi; Tomlins Scott A; Harwood Jason; Schmitz Werner; Conzelmann Ernst; Sanda Martin G; Wei John T; Rubin Mark A; Chinnaiyan Arul M
Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.
The American journal of pathology 2004;164(3):787-93.
2004: Rubin Mark A; De Marzo Angelo M
Molecular genetics of human prostate cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(3):380-8.
2004: Hofer Matthias D; Kuefer Rainer; Varambally Sooryanarayana; Li Haojie; Ma Jing; Shapiro Geoffrey I; Gschwend Juergen E; Hautmann Richard E; Sanda Martin G; Giehl Klaudia; Menke Andre; Chinnaiyan Arul M; Rubin Mark A
The role of metastasis-associated protein 1 in prostate cancer progression.
Cancer research 2004;64(3):825-9.
2004: Rubin Mark A; Kantoff Philip W
Effect of finasteride on risk of prostate cancer: how little we really know.
Journal of cellular biochemistry 2004;91(3):478-82.
2004: Underwood Willie; Wei John; Rubin Mark A; Montie James E; Resh Jennifer; Sanda Martin G
Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.
Urologic oncology 2004;22(1):20-4.
2003: Kuefer Rainer; Hofer Matthias D; Gschwend Juergen E; Pienta Kenneth J; Sanda Martin G; Chinnaiyan Arul M; Rubin Mark A; Day Mark L
The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(17):6447-52.
2003: Kunju Lakshmi P; Rubin Mark A; Chinnaiyan Arul M; Shah Rajal B
Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations.
American journal of clinical pathology 2003;120(5):737-45.
2003: Kleer Celina G; Cao Qi; Varambally Sooryanarayana; Shen Ronglai; Ota Ichiro; Tomlins Scott A; Ghosh Debashis; Sewalt Richard G A B; Otte Arie P; Hayes Daniel F; Sabel Michael S; Livant Donna; Weiss Stephen J; Rubin Mark A; Chinnaiyan Arul M
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(20):11606-11.
2003: Chaib Hassan; MacDonald James W; Vessella Robert L; Washburn Joseph G; Quinn Janna E; Odman Austin; Rubin Mark A; Macoska Jill A
Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors.
Genes, chromosomes & cancer 2003;37(3):306-13.
2003: Fu Zheng; Smith Peter C; Zhang Lizhi; Rubin Mark A; Dunn Rodney L; Yao Zhi; Keller Evan T
Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.
Journal of the National Cancer Institute 2003;95(12):878-89.
2003: Sun Yan-Xi; Wang Jingcheng; Shelburne Charles E; Lopatin Dennis E; Chinnaiyan Arul M; Rubin Mark A; Pienta Kenneth J; Taichman Russell S
Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.
Journal of cellular biochemistry 2003;89(3):462-73.
2003: Nelson Caleb P; Dunn Rodney L; Wei John T; Rubin Mark A; Montie James E; Sanda Martin G
Contemporary preoperative parameters predict cancer-free survival after radical prostatectomy: a tool to facilitate treatment decisions.
Urologic oncology 2003;21(3):213-8.
2003: Rhodes Daniel R; Sanda Martin G; Otte Arie P; Chinnaiyan Arul M; Rubin Mark A
Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.
Journal of the National Cancer Institute 2003;95(9):661-8.
2003: Zhou Ming; Shah Rajal; Shen Ronglai; Rubin Mark A
Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.
The American journal of surgical pathology 2003;27(3):365-71.
2003: Xin Wei; Rhodes Daniel R; Ingold Collette; Chinnaiyan Arul M; Rubin Mark A
Dysregulation of the annexin family protein family is associated with prostate cancer progression.
The American journal of pathology 2003;162(1):255-61.
2003: Rios-Doria Jonathan; Day Kathleen C; Kuefer Rainer; Rashid Michael G; Chinnaiyan Arul M; Rubin Mark A; Day Mark L
The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells.
The Journal of biological chemistry 2003;278(2):1372-9.
2003: Kowalski Paul J; Rubin Mark A; Kleer Celina G
E-cadherin expression in primary carcinomas of the breast and its distant metastases.
Breast cancer research : BCR 2003;5(6):R217-22.
2002: Snyder Kristen M; Rubin Mark A; Shulkin Barry L; Hutchinson Raymond J; Wechsler Daniel S
Mediastinal seminoma in a patient with Wiskott-Aldrich syndrome.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2002;24(8):672-6.
2002: Chay Christopher H; Cooper Carlton R; Gendernalik James D; Dhanasekaran Saravana M; Chinnaiyan Arul M; Rubin Mark A; Schmaier Alvin H; Pienta Kenneth J
A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines.
Urology 2002;60(5):760-5.
2002: Dash Atreya; Maine Ira P; Varambally Sooryanarayana; Shen Ronglai; Chinnaiyan Arul M; Rubin Mark A
Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens.
The American journal of pathology 2002;161(5):1743-8.
2002: Varambally Sooryanarayana; Dhanasekaran Saravana M; Zhou Ming; Barrette Terrence R; Kumar-Sinha Chandan; Sanda Martin G; Ghosh Debashis; Pienta Kenneth J; Sewalt Richard G A B; Otte Arie P; Rubin Mark A; Chinnaiyan Arul M
The polycomb group protein EZH2 is involved in progression of prostate cancer.
Nature 2002;419(6907):624-9.
2002: Xin Wei; Rubin Mark A; McKeever Paul E
Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from rathke cleft cyst.
Archives of pathology & laboratory medicine 2002;126(10):1174-8.
2002: Shah Rajal B; Zhou Ming; LeBlanc Michele; Snyder Matthew; Rubin Mark A
Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
The American journal of surgical pathology 2002;26(9):1161-8.
2002: Kuefer Rainer; Varambally Sooryanarayana; Zhou Ming; Lucas Peter C; Loeffler Martin; Wolter Hubertus; Mattfeldt Torsten; Hautmann Richard E; Gschwend Juergen E; Barrette Terrence R; Dunn Rodney L; Chinnaiyan Arul M; Rubin Mark A
alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation.
The American journal of pathology 2002;161(3):841-8.
2002: Rao Dinesh S; Hyun Teresa S; Kumar Priti D; Mizukami Ikuko F; Rubin Mark A; Lucas Peter C; Sanda Martin G; Ross Theodora S
Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.
The Journal of clinical investigation 2002;110(3):351-60.
2002: Rhodes Daniel R; Barrette Terrence R; Rubin Mark A; Ghosh Debashis; Chinnaiyan Arul M
Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.
Cancer research 2002;62(15):4427-33.
2002: Dash Atreya; Sanda Martin G; Yu Menggang; Taylor Jeremy M G; Fecko Alice; Rubin Mark A
Prostate cancer involving the bladder neck: recurrence-free survival and implications for AJCC staging modification. American Joint Committee on Cancer.
Urology 2002;60(2):276-80.
2002: Zhou Ming; Chinnaiyan Arul M; Kleer Celina G; Lucas Peter C; Rubin Mark A
Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions.
The American journal of surgical pathology 2002;26(7):926-31.
2002: Rubin Mark A
Tech.Sight. Understanding disease cell by cell.
Science (New York, N.Y.) 2002;296(5571):1329-30.
2002: Nelson Caleb P; Rubin Mark A; Strawderman Myla; Montie James E; Sanda Martin G
Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy.
Urology 2002;59(5):740-5; discussion 745-6.
2002: Barkan Güliz Akdas; Rubin Mark A; Michael Claire W
Diagnosis of melanoma aspirates on ThinPrep: the University of Michigan experience.
Diagnostic cytopathology 2002;26(5):334-9.
2002: Rubin Mark A; Zhou Ming; Dhanasekaran Saravana M; Varambally Sooryanarayana; Barrette Terrence R; Sanda Martin G; Pienta Kenneth J; Ghosh Debashis; Chinnaiyan Arul M
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
JAMA : the journal of the American Medical Association 2002;287(13):1662-70.
2002: Seifman Brian D; Rubin Mark A; Williams Antoinette L; Wolf J Stuart
Use of absorbable cyanoacrylate glue to repair an open cystotomy.
The Journal of urology 2002;167(4):1872-5.
2002: Rubin Mark A; Dunn Rodney; Strawderman Myla; Pienta Kenneth J
Tissue microarray sampling strategy for prostate cancer biomarker analysis.
The American journal of surgical pathology 2002;26(3):312-9.
2002: Kleer Celina G; van Golen Kenneth L; Zhang Yanhong; Wu Zhi-Fen; Rubin Mark A; Merajver Sofia D
Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability.
The American journal of pathology 2002;160(2):579-84.
2002: Chinnaiyan Arul M; Rubin Mark A
Gene-expression profiles in hereditary breast cancer.
Advances in anatomic pathology 2002;9(1):1-6.
2001: Wu Y Q; Chen H; Rubin M A; Wojno K J; Cooney K A
Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
Cancer research 2001;61(24):8651-3.
2001: Zhou M; Hayasaka S; Taylor J M; Shah R; Proverbs-Singh T; Manley S; Rubin M A
Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
The Journal of urology 2001;166(6):2193-7.
2001: Rubin M A; Kleter B; Zhou M; Ayala G; Cubilla A L; Quint W G; Pirog E C
Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis.
The American journal of pathology 2001;159(4):1211-8.
2001: Rubin M A
Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer.
The Journal of pathology 2001;195(1):80-6.
2001: Manley S; Mucci N R; De Marzo A M; Rubin M A
Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model.
The American journal of pathology 2001;159(3):837-43.
2001: Dhanasekaran S M; Barrette T R; Ghosh D; Shah R; Varambally S; Kurachi K; Pienta K J; Rubin M A; Chinnaiyan A M
Delineation of prognostic biomarkers in prostate cancer.
Nature 2001;412(6849):822-6.
2001: Kielb S J; Shah N L; Rubin M A; Sanda M G
Functional p53 mutation as a molecular determinant of paclitaxel and gemcitabine susceptibility in human bladder cancer.
The Journal of urology 2001;166(2):482-7.
2001: Rubin M A; Mucci N R; Figurski J; Fecko A; Pienta K J; Day M L
E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Human pathology 2001;32(7):690-7.
2001: Moskalik A P; Rubin M A; Wojno K J; Bree R; Rubin J M; Fowlkes J B; Montie J E; Manley S; Carson P L
Analysis of three-dimensional Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2001;20(7):713-22.
2001: Moskalik A; Carson P L; Rubin J M; Bree R L; Fowlkes J B; Rubin M A; Wojno K; Manley S; Montie J E
Analysis of three-dimensional ultrasound Doppler for the detection of prostate cancer.
Urology 2001;57(6):1128-32.
2001: Shah R; Mucci N R; Amin A; Macoska J A; Rubin M A
Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
The American journal of pathology 2001;158(5):1767-73.
2001: Seifman B D; Rubin M A; Williams A L; Wolf J S
Functional effects of unilateral laser papillectomy in the pig.
Urology 2001;57(4):832-6.
2001: Marcovich R; Williams A L; Rubin M A; Wolf J S
Comparison of 2-octyl cyanoacrylate adhesive, fibrin glue, and suturing for wound closure in the porcine urinary tract.
Urology 2001;57(4):806-10.
2001: Macoska J A; Xu J; Ziemnicka D; Schwab T S; Rubin M A; Kotula L
Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma.
Neoplasia (New York, N.Y.) 2001;3(2):99-104.
2001: Chaib H; Rubin M A; Mucci N R; Li L; Taylor JMG; Day M L; Rhim J S; Macoska J A
Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors.
Cancer research 2001;61(6):2390-4.
2001: Spencer S L; Rubin M A; Hussain H; Wolf J S
Complete transurethral resection of bladder endocervicosis.
The Journal of urology 2001;165(2):524.
2001: Chaib H; Cockrell E K; Rubin M A; Macoska J A
Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis.
Neoplasia (New York, N.Y.) 2001;3(1):43-52.
2001: Rashid M G; Sanda M G; Vallorosi C J; Rios-Doria J; Rubin M A; Day M L
Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate.
Cancer research 2001;61(2):489-92.
2001: Zhou M; Patel A; Rubin M A
Prevalence and location of peripheral nerve found on prostate needle biopsy.
American journal of clinical pathology 2001;115(1):39-43.
2001: Rubin M A; Mucci N R; Manley S; Sanda M; Cushenberry E; Strawderman M; Montie J E; Bassily N H
Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?
The Journal of urology 2001;165(1):114-8.
2000: Rubin M A; Dunn R; Kambham N; Misick C P; O'Toole K M
Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy?
The American journal of surgical pathology 2000;24(12):1634-40.
2000: Mucci N R; Rubin M A; Strawderman M S; Montie J E; Smith D C; Pienta K J
Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens.
Journal of the National Cancer Institute 2000;92(23):1941-2.
2000: Shah R; Bassily N; Wei J; Mucci N R; Montie J E; Sanda M G; Rubin M A
Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors.
Urology 2000;56(5):721-5.
2000: Hollenbeck B K; Bassily N; Wei J T; Montie J E; Hayasaka S; Taylor J M; Rubin M A
Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features.
The Journal of urology 2000;164(5):1583-6.
2000: Perrone E E; Theoharis C; Mucci N R; Hayasaka S; Taylor J M; Cooney K A; Rubin M A
Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men.
Journal of the National Cancer Institute 2000;92(11):937-9.
2000: Marcovich R; Wojno K J; Wei J T; Rubin M A; Montie J E; Sanda M G
Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer.
Urology 2000;55(6):904-8.
2000: Mucci N R; Akdas G; Manely S; Rubin M A
Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression.
Human pathology 2000;31(4):406-14.
2000: Rubin M A; Putzi M; Mucci N; Smith D C; Wojno K; Korenchuk S; Pienta K J
Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):1038-45.
2000: Bassily N H; Vallorosi C J; Akdas G; Montie J E; Rubin M A
Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
American journal of clinical pathology 2000;113(3):383-8.
2000: Rubin M A; Bassily N; Sanda M; Montie J; Strawderman M S; Wojno K
Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma.
The American journal of surgical pathology 2000;24(2):183-9.
2000: Vallorosi C J; Day K C; Zhao X; Rashid M G; Rubin M A; Johnson K R; Wheelock M J; Day M L
Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution.
The Journal of biological chemistry 2000;275(5):3328-34.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Mark Rubin

Research Profile (preview)

Disorders

Chemicals & Drugs

Physiology

Procedures

Concepts & Ideas

Devices

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Mark Rubin (preview)

All Publications